These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077 [TBL] [Abstract][Full Text] [Related]
46. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B; J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Matsumoto Y; Kaneko K; Takahashi T; Takai Y; Namatame C; Kuroda H; Misu T; Fujihara K; Aoki M Brain; 2023 Sep; 146(9):3938-3948. PubMed ID: 37061817 [TBL] [Abstract][Full Text] [Related]
48. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature. Ikeda A; Watanabe Y; Kaba H; Kaneko K; Takahashi T; Takeshita S Brain Dev; 2019 Apr; 41(4):367-372. PubMed ID: 30447856 [TBL] [Abstract][Full Text] [Related]
49. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857 [TBL] [Abstract][Full Text] [Related]
51. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes. Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614 [TBL] [Abstract][Full Text] [Related]
52. Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis. Solmaz I; Doran T; Yousefi M; Konuskan B; Oncel I; Vural A; Anlar B Mult Scler Relat Disord; 2022 Dec; 68():104097. PubMed ID: 35998500 [TBL] [Abstract][Full Text] [Related]
53. The spectrum of MOG autoantibody-associated demyelinating diseases. Reindl M; Di Pauli F; Rostásy K; Berger T Nat Rev Neurol; 2013 Aug; 9(8):455-61. PubMed ID: 23797245 [TBL] [Abstract][Full Text] [Related]
55. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529 [TBL] [Abstract][Full Text] [Related]